Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CONSTELLATION PHARMACEUTICALS INC | Officer, Director | Common Stock | 0 | Jul 15, 2021 | Direct | ||
CONSTELLATION PHARMACEUTICALS INC | Officer, Director | Stock Options (Right to buy) | 0 | Jul 15, 2021 | Direct | ||
Jounce Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | May 3, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JNCE | Jounce Therapeutics, Inc. | May 3, 2023 | 2 | $0 | 4 | May 4, 2023 | Director |
JNCE | Jounce Therapeutics, Inc. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
JNCE | Jounce Therapeutics, Inc. | Sep 13, 2021 | 1 | $0 | 4 | Sep 15, 2021 | Director |
JNCE | Jounce Therapeutics, Inc. | Sep 13, 2021 | 0 | $0 | 3 | Sep 15, 2021 | Director |
CNST | CONSTELLATION PHARMACEUTICALS INC | Jul 15, 2021 | 8 | $0 | 4 | Jul 19, 2021 | Officer, Director |